Literature DB >> 9415348

Estimating the cost effectiveness of screening tests.

D J Torgerson1, D M Reid.   

Abstract

A number of criteria have been postulated that a screening test should fulfill in order for it to be a good or worthwhile screening tool. However, it is a rare test which fulfills all the criteria that have been thought to be important. Therefore, there always exists some form of trade-off between, for example, the detection rate and the false-positive rate and cost. It is the magnitude and form of these trade-offs, which differ for each screening test, that are important, not whether a test fulfills some arbitrary set of criteria. In this paper, we describe some of the trade-offs which occur when appraising a screening test and we argue that listing arbitrary criteria is an unhelpful activity.

Mesh:

Year:  1997        PMID: 9415348     DOI: 10.1093/qjmed/90.10.649

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  1 in total

1.  The pharmacoeconomics of hormone replacement therapy.

Authors:  D J Torgerson; D M Reid
Journal:  Pharmacoeconomics       Date:  1999-07       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.